The estimated Net Worth of Mitchell E. Levinson is at least $565 Tisíc dollars as of 15 November 2023. Mr. Levinson owns over 17,800 units of Pulse Biosciences Inc stock worth over $17,808 and over the last 7 years he sold PLSE stock worth over $0. In addition, he makes $547,494 as Independent Director at Pulse Biosciences Inc.
Sign up
Mr. Levinson PLSE stock SEC Form 4 insiders trading
Mitchell has made over 3 trades of the Pulse Biosciences Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 17,800 units of PLSE stock worth $105,020 on 15 November 2023.
The largest trade he's ever made was buying 30,780 units of Pulse Biosciences Inc stock on 7 October 2022 worth over $69,871. On average, Mitchell trades about 2,759 units every 119 days since 2017. As of 15 November 2023 he still owns at least 1,039 units of Pulse Biosciences Inc stock.
You can see the complete history of Mr. Levinson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mitchell Levinson biography
Mitchell E. Levinson serves as Independent Director of the Company. Mr. Levinson has served as a director since March 2019 and previously served as a director from January 2015 to November 2017. Since October 2018, Mr. Levinson has been a board member and Chief Technology Officer of Cerebrotech Medical Systems, Inc., a neurotechnology device company focused on the development of portable neurotechnology solutions that he co-founded during 2010. Mr. Levinson also served as President and Chief Executive Officer of Cerebrotech Medical Systems from December 2010 to October 2018. Prior to 2010, Mr. Levinson was the start-up Chief Executive Officer for Zeltiq Aesthetics Inc. where he became its first employee in 2005 and served as its president and its Chief Executive Officer from September 2005 until September 2009. He continued with Zeltiq as Chief Scientific Officer from September 2009 through December 2010. From March 2000 to September 2005, he served as Vice President of Research and Development of Thermage, Inc. (later renamed Solta Medical Inc.), a company engaged in cosmetic tissue tightening devices. He is the inventor of 48 issued and numerous pending U.S. patents. Mr. Levinson earned his B.S. in Mechanical Engineering from University of California at San Diego and holds an M.S in Computer Systems from the University of Phoenix.
What is the salary of Mitchell Levinson?
As the Independent Director of Pulse Biosciences Inc, the total compensation of Mitchell Levinson at Pulse Biosciences Inc is $547,494. There are 4 executives at Pulse Biosciences Inc getting paid more, with Sandra Gardiner having the highest compensation of $2,097,570.
How old is Mitchell Levinson?
Mitchell Levinson is 59, he's been the Independent Director of Pulse Biosciences Inc since 2019. There are 5 older and 6 younger executives at Pulse Biosciences Inc. The oldest executive at Pulse Biosciences Inc is Robert Duggan, 75, who is the Independent Chairman of the Board.
What's Mitchell Levinson's mailing address?
Mitchell's mailing address filed with the SEC is 3957 POINT EDEN WAY, , HAYWARD, CA, 94545.
Insiders trading at Pulse Biosciences Inc
Over the last 8 years, insiders at Pulse Biosciences Inc have traded over $0 worth of Pulse Biosciences Inc stock and bought 18,070,761 units worth $194,618,110 . The most active insiders traders include Robert W Duggan, Mahkam Zanganeh a Manmeet Singh Soni. On average, Pulse Biosciences Inc executives and independent directors trade stock every 52 days with the average trade being worth of $6,179,107. The most recent stock trade was executed by Burke Thomas Barrett on 20 May 2024, trading 10,000 units of PLSE stock currently worth $85,600.
What does Pulse Biosciences Inc do?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
What does Pulse Biosciences Inc's logo look like?
Complete history of Mr. Levinson stock trades at Pulse Biosciences Inc
Pulse Biosciences Inc executives and stock owners
Pulse Biosciences Inc executives and other stock owners filed with the SEC include:
-
Sandra Gardiner,
Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary -
Darrin Uecker,
President, Chief Executive Officer, Director -
Darrin R. Uecker,
Pres, CEO & Director -
Sandra A. Gardiner,
Exec. VP of Fin. & Admin., CFO, Sec. and Treasurer -
Mitchell Levinson,
Independent Director -
Edward A. Ebbers,
Exec. VP & GM of Dermatology -
Edward Ebbers,
Executive Vice President, General Manager - Dermatology -
Manmeet Soni,
Independent Director -
Robert Duggan,
Independent Chairman of the Board -
Kenneth Clark,
Independent Director -
Mahkam Zanganeh,
Independent Director -
Mitchell E. Levinson,
Chief Strategy Officer & Director -
David Danitz,
Sr. VP of Engineering -
Patty Perla,
VP of HR -
Dr. Holly Hartman Ph.D., J.D.,
VP of Bus. Devel. & Corp. Strategy -
Dr. Richard Nuccitelli Ph.D.,
Chief Science Officer -
Thierry B. Thaure,
Director -
Robert J. Greenberg,
Director -
Robert Levande,
Director -
Brian B Dow,
CFO & SVP Admin. and Finance -
Thomas J M D Fogarty,
Director -
Burke Thomas Barrett,
President and CEO -
Ed Ebbers,
EVP & GM, Dermatology -
Den Broek Richard Van,
Director -
Laureen Debuono,
Director -
Shelley D Spray,
Director -
Kevin Patrick Danahy,
Chief Commercial Officer -
Paul A Laviolette,
Director